Structure prediction of eukaryotic elongation factor-2 kinase and identification of the binding mechanisms of its inhibitors: homology modeling, molecular docking, and molecular dynamics simulation

References

• Akbay, N., Taskin Tok, T., Seferoğlu, Z., & Gökoğlu, E. (2018). Investigation of binding properties of two ethidium derivatives with serum albumins: Spectral and computational approach. Journal of Biomolecular Structure & Dynamics, 36(12), 3114–3121. doi:10.1080/07391102.2017.1380536
   PubMed Web of Science ®Google Scholar
• Anusuya, S., & Gromiha, M. M. (2019). Structural basis of flavonoids as dengue polymerase inhibitors: insights from QSAR and docking studies. Journal of Biomolecular Structure & Dynamics, 37(1), 104–115. doi:10.1080/07391102.2017.1419146
   PubMed Web of Science ®Google Scholar
• Arora, A. (2005). Role of tyrosine kinase inhibitors in cancer therapy. Journal of Pharmacology and Experimental Therapeutics, 315(3), 971–979. doi:10.1124/jpet.105.084145
   PubMed Web of Science ®Google Scholar
• Ashour, A. A., Abdel-Aziz, A.-A. H., Mansour, A. M., Alpay, S. N., Huo, L., & Ozpolat, B. (2014). Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells. Apoptosis, 19(1), 241–258. doi:10.1007/s10495-013-0927-2
   PubMed Web of Science ®Google Scholar
• Ballazhi, L., Imeri, F., Dimovski, A., Jashari, A., Popovski, E., Breznica-Selmani, P., … Mladenovska, K. (2014). Synergy of novel coumarin derivatives and tamoxifen in blocking growth and inducing apoptosis of breast cancer cells. Macedonian pharmaceutical bulletin, 60(1), 35–44.
   Google Scholar
• Bayel Secinti, B., Tatar, G., & Taskin Tok, T. (2018). Determination of potential selective inhibitors for ROCKI and ROCKII isoforms with molecular modeling techniques: Structure based docking, ADMET and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 26, 1–7. doi:10.1080/07391102.2018.1491420
   Google Scholar
• Becke, A. D. (1993). Density‐functional thermochemistry. III. The role of exact exchange. The Journal of Chemical Physics, 98(7), 5648–5652. doi:10.1063/1.464913
   Web of Science ®Google Scholar
• Beria, I., Bossi, R. T., Brasca, M. G., Caruso, M., Ceccarelli, W., Fachin, G., … Valsasina, B. (2011). NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor. Bioorganic & Medicinal Chemistry Letters, 21(10), 2969–2974. doi:10.1016/j.bmcl.2011.03.054
   PubMed Web of Science ®Google Scholar
• Brasca, M. G., Mantegani, S., Amboldi, N., Bindi, S., Caronni, D., Casale, E., … Fogliatto, G. (2013). Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90). Bioorganic & Medicinal Chemistry, 21(22), 7047–7063. doi:10.1016/j.bmc.2013.09.018
   PubMed Web of Science ®Google Scholar
• Browne, G. J., Finn, S. G., & Proud, C. G. (2004). Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. Journal of Biological Chemistry, 279(13), 12220–12231. doi:10.1074/jbc.M309773200
   PubMed Web of Science ®Google Scholar
• Brylinski, M., & Skolnick, J. (2010). Comprehensive structural and functional characterization of the human kinome by protein structure modeling and ligand virtual screening. Journal of Chemical Information and Modeling, 50(10), 1839–1854. doi:10.1021/ci100235n
   PubMed Web of Science ®Google Scholar
• Casale, E., Amboldi, N., Brasca, M. G., Caronni, D., Colombo, N., Dalvit, C., … Casuscelli, F. (2014). Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors. Bioorganic & Medicinal Chemistry, 22(15), 4135–4150. doi:10.1016/j.bmc.2014.05.056
   PubMed Web of Science ®Google Scholar
• Casuscelli, F., Ardini, E., Avanzi, N., Casale, E., Cervi, G., D’Anello, M., … Felder, E. R. (2013). Discovery and optimization of pyrrolo[1,2-a]pyrazinones leads to novel and selective inhibitors of PIM kinases. Bioorganic & Medicinal Chemistry, 21(23), 7364–7380. doi:10.1016/j.bmc.2013.09.054
   PubMed Web of Science ®Google Scholar
• Chen, Z., Gopalakrishnan, S. M., Bui, M.-H., Soni, N. B., Warrior, U., Johnson, E. F., … Glaser, K. B. (2011). 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): A cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor. Journal of Biological Chemistry, 286(51), 43951–43958. doi:10.1074/jbc.M111.301291
   PubMed Web of Science ®Google Scholar
• Chilin, A., Battistutta, R., Bortolato, A., Cozza, G., Zanatta, S., Poletto, G., … Moro, S. (2008). Coumarin as attractive casein kinase 2 (CK2) inhibitor scaffold: An integrate approach to elucidate the putative binding motif and explain structure–activity relationships. Journal of Medicinal Chemistry, 51(4), 752–759. doi:10.1021/jm070909t
   PubMed Web of Science ®Google Scholar
• Dassault Systèmes BIOVIA. (2016). Discovery studio modeling environment, release 2017. San Diego: Dassault Systèmes.
   Google Scholar
• Davies, S. P., Reddy, H., Caivano, M., & Cohen, P. (2000). Specificity and mechanism of action of some commonly used protein kinase inhibitors, Biochemical Journal, 351, 95–105.
   Google Scholar
• Devkota, A. K., Tavares, C. D. J., Warthaka, M., Abramczyk, O., Marshall, K. D., Kaoud, T. S., … Dalby, K. N. (2012). Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: Evidence of a common in vitro artifact. Biochemistry, 51(10), 2100–2112. doi:10.1021/bi201787p
   PubMed Web of Science ®Google Scholar
• Devkota, A. K., Warthaka, M., Edupuganti, R., Tavares, C. D. J., Johnson, W. H., Ozpolat, B., … Dalby, K. N. (2014). High-throughput screens for eEF-2 kinase. Journal of Biomolecular Screening, 19(3), 445–452. doi:10.1177/1087057113505204
   PubMedGoogle Scholar
• Edupuganti, R., Wang, Q., Tavares, C. D. J., Chitjian, C. A., Bachman, J. L., Ren, P., … Dalby, K. N. (2014). Synthesis and biological evaluation of pyrido[2,3-d]pyrimidine-2,4-dione derivatives as eEF-2K inhibitors. Bioorganic & Medicinal Chemistry, 22(17), 4910–4916. doi:10.1016/j.bmc.2014.06.050
   PubMed Web of Science ®Google Scholar
• Faivre, S., Djelloul, S., & Raymond, E. (2006). New paradigms in anticancer therapy: Targeting multiple signaling pathways with kinase inhibitors. Seminars in Oncology, 33(4), 407–420. doi:10.1053/j.seminoncol.2006.04.005
   PubMed Web of Science ®Google Scholar
• Fedorov, O., Marsden, B., Pogacic, V., Rellos, P., Muller, S., Bullock, A. N., … Knapp, S. (2007). A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases. Proceedings of the National Academy of Sciences United States of America, 104(51), 20523–20528. doi:10.1073/pnas.0708800104
   PubMed Web of Science ®Google Scholar
• Fiser, A., & Šali, A. (2003). Modeller: Generation and refinement of homology-based protein structure models. In Methods in enzymology (Vol. 374, pp. 461–491). Amsterdam, The Netherlands: Elsevier. https://doi.org/10.1016/S0076-6879(03)74020-8
   Google Scholar
• Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., … Leach, A. R. (2017). The ChEMBL database in 2017. Nucleic Acids Research, 45(D1), D945–D954. doi:10.1093/nar/gkw1074
   PubMed Web of Science ®Google Scholar
• Gschwendt, M., Kittstein, W., & Marks, F. (1994). Elongation factor-2 kinase: effective inhibition by the novel protein kinase inhibitor rottlerin and relative insensitivity towards staurosporine. FEBS Letters, 338(1), 85–88. https://doi.org/10.1016/0014-5793(94)80121-5 doi:10.1016/0014-5793(94)80121-5
   PubMed Web of Science ®Google Scholar
• Guo, Y., Zhao, Y., Wang, G., Chen, Y.-C., Jiang, Y., Ouyang, L., & Liu, B. (2018). Design, synthesis and structure-activity relationship of a focused library of β-phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer. European Journal of Medicinal Chemistry, 143, 402–418. doi:10.1016/j.ejmech.2017.11.065
   PubMed Web of Science ®Google Scholar
• Han, S., Zhou, V., Pan, S., Liu, Y., Hornsby, M., McMullan, D., … Gu, X. (2005). Identification of coumarin derivatives as a novel class of allosteric MEK1 inhibitors. Bioorganic & Medicinal Chemistry Letters, 15(24), 5467–5473. doi:10.1016/j.bmcl.2005.08.097
   PubMed Web of Science ®Google Scholar
• Hardie, D. G. (2014). AMP-activated protein kinase: Maintaining energy homeostasis at the cellular and whole body levels. Annual Review of Nutrition, 34(1), 31–55. doi:10.1146/annurev-nutr-071812-161148
   PubMedGoogle Scholar
• Hizli, A. A., Chi, Y., Swanger, J., Carter, J. H., Liao, Y., Welcker, M., … Clurman, B. E. (2013). Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A-cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase. Molecular and Cellular Biology, 33(3), 596–604. doi:10.1128/MCB.01270-12
   PubMed Web of Science ®Google Scholar
• Hori, H. (2002). TX-1123: An antitumor 2-hydroxyarylidene-4-cyclopentene-1,3-dione as a protein tyrosine kinase inhibitor having low mitochondrial toxicity. Bioorganic & Medicinal Chemistry, 10, 3257–3265. https://doi.org/10.1016/s0968-0896(02)00160-8 doi:10.1016/S0968-0896(02)00160-8
   PubMed Web of Science ®Google Scholar
• Horman, S., Browne, G. J., Krause, U., Patel, J. V., Vertommen, D., Bertrand, L., … Rider, M. H. (2002). Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Current Biology, 12(16), 1419–1423. https://doi.org/10.1016/s0960-9822(02)01077-1 doi:10.1016/S0960-9822(02)01077-1
   PubMed Web of Science ®Google Scholar
• Huang, J., & MacKerell, A. D. (2013). CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. Journal of Computational Chemistry, 34(25), 2135–2145. doi:10.1002/jcc.23354
   PubMed Web of Science ®Google Scholar
• Johnson, M. S., Srinivasan, N., Sowdhamini, R., & Blundell, T. L. (1994). Knowledge-based protein modeling. Critical Reviews in Biochemistry and Molecular Biology, 29(1), 1–68. doi:10.3109/10409239409086797
   PubMed Web of Science ®Google Scholar
• Kumar, R., Jade, D., & Gupta, D. (2019). A novel identification approach for discovery of 5-hydroxytriptamine 2A antagonists: Combination of 2D/3D similarity screening, molecular docking and molecular dynamics. Journal of Biomolecular Structure & Dynamics, 37(4), 931–943. doi:10.1080/07391102.2018.1444509
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK: A program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2), 283–291. doi:10.1107/S0021889892009944
   Web of Science ®Google Scholar
• Leprivier, G., Remke, M., Rotblat, B., Dubuc, A., Mateo, A.-R. F., Kool, M., … Sorensen, P. H. (2013). The eEF2 kinase confers resistance to nutrient deprivation by blocking translation elongation. Cell, 153(5), 1064–1079. doi:10.1016/j.cell.2013.04.055
   PubMed Web of Science ®Google Scholar
• Lockman, J. W., Reeder, M. D., Suzuki, K., Ostanin, K., Hoff, R., Bhoite, L., … Adam Willardsen, J. (2010). Inhibition of eEF2-K by thieno[2,3-b]pyridine analogues. Bioorganic & Medicinal Chemistry Letters, 20(7), 2283–2286. doi:10.1016/j.bmcl.2010.02.005
   PubMed Web of Science ®Google Scholar
• Lovell, S. C., Davis, I. W., Arendall, W. B., de Bakker, P. I. W., Word, J. M., Prisant, M. G., … Richardson, D. C. (2003). Structure validation by Calpha geometry: phi, psi and Cbeta deviation. Proteins: Structure, Function, and Bioinformatics, 50(3), 437–450. doi:10.1002/prot.10286
   PubMed Web of Science ®Google Scholar
• Lüthy, R., Bowie, J. U., & Eisenberg, D. (1992). Assessment of protein models with three-dimensional profiles. Nature, 356(6364), 83–85. doi:10.1038/356083a0
   PubMed Web of Science ®Google Scholar
• Manning, G. (2002). The protein kinase complement of the human genome. Science, 298(5600), 1912–1934. doi:10.1126/science.1075762
   PubMed Web of Science ®Google Scholar
• Menichincheri, M., Ardini, E., Magnaghi, P., Avanzi, N., Banfi, P., Bossi, R., … Orsini, P. (2016). Discovery of entrectinib: A new 3-aminoindazole as a potent anaplastic lymphoma kinase (ALK), c-ros oncogene 1 kinase (ROS1), and pan-tropomyosin receptor kinases (Pan-TRKs) inhibitor. Journal of Medicinal Chemistry, 59(7), 3392–3408. doi:10.1021/acs.jmedchem.6b00064
   PubMed Web of Science ®Google Scholar
• Abraham, M. J., van der Spoel, D., Lindahl, E., & Hess, B.; and the GROMACS development team. (2018). GROMACS user manual version. www.gromacs.org (2018).
   Google Scholar
• Frisch, M. J., Kamyonlar, G. W., Schlegel, H. B. (2016). Gauss 09 Gauss Inc. Wallingford, CT: Gauss 09 Gauss Inc.
   Google Scholar
• Molenaar, J. J., Koster, J., Zwijnenburg, D. A., van Sluis, P., Valentijn, L. J., van der Ploeg, I., … Versteeg, R. (2012). Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes. Nature, 483(7391), 589–593. doi:10.1038/nature10910
   PubMed Web of Science ®Google Scholar
• Monteggia, L. M., Gideons, E., & Kavalali, E. T. (2013). The role of eEF2 kinase in rapid antidepressant action of ketamine. Biological Psychiatry, 73(12), 1199–1203. doi:10.1016/j.biopsych.2012.09.006
   PubMed Web of Science ®Google Scholar
• Moore, C. E. J., Wang, X., Xie, J., Pickford, J., Barron, J., Regufe da Mota, S., … Proud, C. G. (2016). Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy. Cellular Signalling, 28(4), 284–293. doi:10.1016/j.cellsig.2016.01.005
   PubMed Web of Science ®Google Scholar
• Moore, C. E., Regufe da Mota, S., Mikolajek, H., & Proud, C. G. (2014). A conserved loop in the catalytic domain of eukaryotic elongation factor 2 kinase plays a key role in its substrate specificity. Molecular and Cellular Biology, 34(12), 2294–2307. doi:10.1128/MCB.00388-14
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and Autodocktools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. doi:10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Pan, Z., Chen, Y., Liu, J., Jiang, Q., Yang, S., Guo, L., & He, G. (2018). Design, synthesis, and biological evaluation of polo-like kinase 1/eukaryotic elongation factor 2 kinase (PLK1/EEF2K) dual inhibitors for regulating breast cancer cells apoptosis and autophagy. European Journal of Medicinal Chemistry, 144, 517–528. doi:10.1016/j.ejmech.2017.12.046
   PubMed Web of Science ®Google Scholar
• Papeo, G., Posteri, H., Borghi, D., Busel, A. A., Caprera, F., Casale, E., … Montagnoli, A. (2015). Discovery of 2-[1-(4,4-difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1 H-isoindole-4-carboxamide (NMS-P118): A potent, orally available, and highly selective PARP-1 inhibitor for cancer therapy. Journal of Medicinal Chemistry, 58(17), 6875–6898. doi:10.1021/acs.jmedchem.5b00680
   PubMed Web of Science ®Google Scholar
• Pavur, K. S., Petrov, A. N., & Ryazanov, A. G. (2000). Mapping the functional domains of elongation factor-2 kinase. Biochemistry, 39(40), 12216–12224. doi:10.1021/bi0007270
   PubMed Web of Science ®Google Scholar
• Ramachandran, G. N., Ramakrishnan, C., & Sasisekharan, V. (1963). Stereochemistry of polypeptide chain configurations. Journal of Molecular Biology, 7(1), 95–99. https://doi.org/10.1016/S0022-2836(63)80023-6 doi:10.1016/S0022-2836(63)80023-6
   PubMed Web of Science ®Google Scholar
• Shen, M.-Y., & Sali, A. (2006). Statistical potential for assessment and prediction of protein structures. Protein Science, 15(11), 2507–2524. doi:10.1110/ps.062416606
   PubMed Web of Science ®Google Scholar
• Sippl, M. J. (1993). Recognition of errors in three-dimensional structures of proteins. Proteins: Structure, Function, and Genetics, 17(4), 355–362. doi:10.1002/prot.340170404
   PubMed Web of Science ®Google Scholar
• Sippl, M. J. (1995). Knowledge-based potentials for proteins. Current Opinion in Structural Biology, 5(2), 229–235. doi:10.1016/0959-440X(95)80081-6
   PubMed Web of Science ®Google Scholar
• Sixto-López, Y., Bello, M., & Correa-Basurto, J. (2019). Insights into structural features of HDAC1 and its selectivity inhibition elucidated by molecular dynamic simulation and molecular docking. Journal of Biomolecular Structure & Dynamics, 37(3), 584–610. doi:10.1080/07391102.2018.1441072
   PubMed Web of Science ®Google Scholar
• Tatar, G. (2018). Structure prediction of eukaryotic elongation factor 2 kinase (eEF-2K) and elucidation of binding mechanisms of its novel compounds with molecular modelling applications (PhD thesis). Gaziantep University.
   Google Scholar
• Traquandi, G., Ciomei, M., Ballinari, D., Casale, E., Colombo, N., Croci, V., … Brasca, M. G. (2010). Identification of potent pyrazolo[4,3- h] quinazoline-3-carboxamides as multi-cyclin-dependent kinase inhibitors. Journal of Medicinal Chemistry, 53(5), 2171–2187. doi:10.1021/jm901710h
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., … MacKerell, A. D. (2010). CHARMM general force field (CGenFF): A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. Journal of Computational Chemistry, 31(4), 671–690. doi:10.1002/jcc.21367
   PubMed Web of Science ®Google Scholar
• Weatherill, D. B., McCamphill, P. K., Pethoukov, E., Dunn, T. W., Fan, X., & Sossin, W. S. (2011). Compartment-specific, differential regulation of eukaryotic elongation factor 2 and its kinase within Aplysia sensory neurons: Regulation of eEF2 kinase in Aplysia. Journal of Neurochemistry, 117(5), 841–855. doi:10.1111/j.1471-4159.2011.07251.x
   PubMed Web of Science ®Google Scholar
• Wiederstein, M., & Sippl, M. J. (2007). ProSA-web: Interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Research, 35(Web Server issue), W407–W410. doi:10.1093/nar/gkm290
   PubMed Web of Science ®Google Scholar
• Wu, H., Jin, S., & Yang1, J.-M. (2006). Elongation factor-2 kinase: Its role in protein synthesis and autophagy. Autophagy, 2(4), 294–296. doi:10.4161/auto.2857
   PubMed Web of Science ®Google Scholar
• Ye, Q., Crawley, S. W., Yang, Y., Cote, G. P., & Jia, Z. (2010). Crystal structure of the kinase domain of dictyostelium myosin heavy chain kinase A. Science Signaling, 3(111), ra17–ra17. doi:10.1126/scisignal.2000525
   PubMed Web of Science ®Google Scholar
• Ye, Q., Yang, Y., van Staalduinen, L., Crawley, S. W., Liu, L., Brennan, S., … Jia, Z. (2016). Structure of the dictyostelium myosin-II heavy chain kinase A (MHCK-A) α-kinase domain apoenzyme reveals a novel autoinhibited conformation. Scientific Reports, 6(1), 26634. https://doi.org/10.1038/srep26634
   PubMedGoogle Scholar
• Zhao, F., Jin, W., Ma, L., Zhang, J.-Y., Wang, J.-L., Zhang, J.-H., & Song, Y.-B. (2019). Investigation of the selectivity of one type of small-molecule inhibitor for three Nav channel isoforms based on the method of computer simulation. Journal of Biomolecular Structure & Dynamics, 37(3), 702–713. doi:10.1080/07391102.2018.1438921
   PubMed Web of Science ®Google Scholar